EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index

Lea Ueberham iD, Jonas Schädlich iD, Kim Schramke, Sebastian Braun iD, Christoph Selg iD, Markus Laube iD, Peter Lönnecke iD, Jens Pietzsch iD, Evamarie Hey-Hawkins iD

ChemMedChem · 02.06.2025 · 20 (11)

DOI: 10.1002/cmdc.202500166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 04.05.2025. Verfasst von Lea Ueberham und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Biotechnology and Biomedicine (BBZ), Faculty of Chemistry and Mineralogy, Institute of Bioanalytical Chemistry, Universität Leipzig, Deuts…. Hauptthemen laut MEDLINE: Flurbiprofen, Celecoxib, Cyclooxygenase 1, Cyclooxygenase 2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, CRC-Transregio, European Union - NextGenerationEU and the Romanian Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cylcooxygenase isoforms COX‐1 and COX‐2 are involved in the production of prostaglandins in physiological and pathological processes. The overexpression of COX‐2 under inflammatory conditions, its role in cancer and neurodegenerative diseases necessitates the need to develop and improve nonsteroidal anti‐inflammatory drugs. These mainly unselective COX inhibitors, e.g. aspirin, are used to reduce the symptoms of inflammation. To reduce unwanted side effects connected with unselective inhibition, the development of novel COX‐2 selective inhibitors is a major goal. Herein, the synthesis, characterization and in vitro biological evaluation of eight flurbiprofen‐ and celecoxib‐based carborane analogs are described. Carboranes as hydrophobic surrogates are suitable substituents that can contribute to a selectivity increase toward COX‐2 due to size exclusion. The inhibitory efficacy for COX‐1 and COX‐2 of the four ortho ‐ and four nido ‐carborane derivatives has been tested. The nido compounds are much more potent than their closo ‐carborane analogs. The celecoxib‐based nido ‐carborane compound 10 shows an IC 50 (COX‐2) value in the sub‐μM range and slight selectivity for COX‐2. This is in contrast to its ortho ‐carborane counterpart 9 , which shows an inhibition preference for COX‐1. While none of these carborane derivatives outperforms their organic analogs, the flurbiprofen‐based nido ‐carborane derivatives 14a and 14b surpass the known carborane‐based flurbiprofen analogs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlurbiprofenCelecoxibCyclooxygenase 1Cyclooxygenase 2Cyclooxygenase InhibitorsBoranesCyclooxygenase 2 InhibitorsHumansStructure-Activity RelationshipMolecular StructureAnti-Inflammatory Agents, Non-SteroidalDose-Response Relationship, Drug

Stichwörter der Autor:innen

bioisosterismcarboranescyclooxygenaseinflammationnonsteroidal anti‐inflammatory drug

Substanzen

FlurbiprofenCelecoxibCyclooxygenase 1Cyclooxygenase 2Cyclooxygenase InhibitorsBoranesCyclooxygenase 2 InhibitorsAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Centre for Biotechnology and Biomedicine (BBZ), Faculty of Chemistry and Mineralogy, Institute of Bioanalytical Chemistry, Universität Leipzig, Deutscher Platz 5, 04103, Leipzig, Germany.
  • Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Bautzner Landstraße 400, 01328, Dresden, Germany.
  • School of Science, Faculty of Chemistry and Food Chemistry, Technische Universität Dresden, Mommsenstraße 4, 01062, Dresden, Germany.
  • Faculty of Chemistry and Chemical Engineering Department of Chemistry, Babeş-Bolyai University, Str. Arany Janos Nr. 11, RO-400028, Cluj-Napoca, Romania.

ORCID-Profile: Lea Ueberham, Jonas Schädlich, Sebastian Braun, Christoph Selg, Markus Laube, Peter Lönnecke, Jens Pietzsch, Evamarie Hey-Hawkins

Förderung

  • German Research Foundation
  • CRC-Transregio
  • European Union - NextGenerationEU and the Romanian Government
  • Deutsche Forschungsgemeinschaft
  • Bundesministerium für Bildung und Forschung

Zitieren

APA

Ueberham, L., Schädlich, J., Schramke, K., Braun, S., Selg, C., Laube, M., Lönnecke, P., Pietzsch, J., & Hey-Hawkins, E. (2025). Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index. ChemMedChem, 20(11). https://doi.org/10.1002/cmdc.202500166

Vancouver

Ueberham L, Schädlich J, Schramke K, Braun S, Selg C, Laube M, et al. Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index. ChemMedChem. 2025;20(11). doi:10.1002/cmdc.202500166

BibTeX
@article{Ueberham2025,
  author = {Ueberham, Lea and Schädlich, Jonas and Schramke, Kim and Braun, Sebastian and Selg, Christoph and Laube, Markus and Lönnecke, Peter and Pietzsch, Jens and Hey-Hawkins, Evamarie},
  title = {Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index},
  journal = {ChemMedChem},
  year = {2025},
  volume = {20},
  number = {11},
  doi = {10.1002/cmdc.202500166}
}
Kostenlos starten →